Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Development & Bioavailability
  6.  » CDMO Perspective on Partnering with Clients from Phase I through Commercialization
Webinar icon

CDMO Perspective on Partnering with Clients from Phase I through Commercialization

Summary: There are several key considerations when choosing a contract development and manufacturing organization (CDMO) for the development and commercialization of your product, including the evolution of your product from early phase development to phase III, ensuring a seamless transition throughout the development phases into commercialization, and the robustness of the manufacturing process. Sponsors also need to consider their external manufacturing partner’s capacity, capabilities, and technical expertise to troubleshoot and overcome challenges prior to launch.

CDMOs such as Catalent should work with you to find the best delivery solution for your product and the targeted patient population to help ensure commercial and market success.

Click here to view the video